Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Parkinson Disease Excellence Forum

Parkinson Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

DNL201 and LRRK2 Inhibition in Parkinson Disease: Phase 1b Trial Results
Podcasts
01/04/2021
In this podcast, Joohi Jimenez-Shahed, MD, discusses the findings of the study, “Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson's Disease Patients with and without LRRK2...
In this podcast, Joohi Jimenez-Shahed, MD, discusses the findings of the study, “Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson's Disease Patients with and without LRRK2...
In this podcast, Joohi...
01/04/2021
Neurology
Parkinson Disease: Noninvasive Retinal Imaging Parameters May Be Potential Biomarkers
Q&As
12/30/2020
Researchers answered our questions about their recent study, which suggested that noninvasive retinal imaging parameters should be investigated further as potential biomarkers of Parkinson disease.
Researchers answered our questions about their recent study, which suggested that noninvasive retinal imaging parameters should be investigated further as potential biomarkers of Parkinson disease.
Researchers answered our...
12/30/2020
Neurology
Advances in Clinical Genetic Testing for Parkinson Disease
Q&As
12/02/2020
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual...
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual...
Neurology Learning Network spoke...
12/02/2020
Neurology
Alastair Noyce, MD, on Access to Parkinson Medication During COVID-19
Podcasts
11/25/2020
Alastair Noyce, MD, discusses his recent study, which found that patients with Parkinson disease have likely had less access to medication during the COVID-19 pandemic, which in turn may impact patients' symptomatic control.
Alastair Noyce, MD, discusses his recent study, which found that patients with Parkinson disease have likely had less access to medication during the COVID-19 pandemic, which in turn may impact patients' symptomatic control.
Alastair Noyce, MD, discusses...
11/25/2020
Neurology
α-Synuclein Active Immunotherapeutic Drug Appears Safe and Effective, and Generates Immune Response in Parkinson Disease
Q&As
11/20/2020
Early findings presented at the International Parkinson and Movement Disorders 2020 Virtual Congress indicate that an α-synuclein active immunotherapeutic drug appears to be safe and well-tolerated, and generated a substantial humoral immune...
Early findings presented at the International Parkinson and Movement Disorders 2020 Virtual Congress indicate that an α-synuclein active immunotherapeutic drug appears to be safe and well-tolerated, and generated a substantial humoral immune...
Early findings presented at the...
11/20/2020
Neurology
Bhavya R. Shah, MD, on Advanced MRI Techniques for Transcranial HIFU Targeting
Podcasts
10/14/2020
In this podcast, Dr Shah discusses the imaging and treatment modalities he and his colleagues reviewed in their recent article, "Advanced MRI techniques for transcranial high intensity focused ultrasound targeting," which was published in the...
In this podcast, Dr Shah discusses the imaging and treatment modalities he and his colleagues reviewed in their recent article, "Advanced MRI techniques for transcranial high intensity focused ultrasound targeting," which was published in the...
In this podcast, Dr Shah...
10/14/2020
Neurology
5 Questions on α-Synuclein Reactive T Cells and Preclinical Parkinson Disease
Published in Partnership
06/22/2020
New findings suggest that α-synuclein reactive T cells may be present years before the diagnosis of motor Parkinson disease. Neurology Consultant discussed these findings further with study author David Sulzer, PhD, from Columbia University...
New findings suggest that α-synuclein reactive T cells may be present years before the diagnosis of motor Parkinson disease. Neurology Consultant discussed these findings further with study author David Sulzer, PhD, from Columbia University...
New findings suggest that...
06/22/2020
Neurology
4 Questions About Advanced MRI Techniques for Transcranial HIFU Targeting
Q&As
04/28/2020
A new review indicates that newer, advanced MRI technology can serve as a “promising alternative” to subjective landmark-based methods for transcranial high intensity focused ultrasound targeting. Neurology Consultant discussed the...
A new review indicates that newer, advanced MRI technology can serve as a “promising alternative” to subjective landmark-based methods for transcranial high intensity focused ultrasound targeting. Neurology Consultant discussed the...
A new review indicates that...
04/28/2020
Neurology
Videos
08/21/2019
Allison Willis, MD, discusses efforts to address the "female paradox of Parkinson disease."
Allison Willis, MD, discusses efforts to address the "female paradox of Parkinson disease."
Allison Willis, MD, discusses...
08/21/2019
Neurology
Q&As
04/25/2019
Gal Bitan, PhD, from UCLA, answers our questions about his research on a potential blood test for diagnosing PD, which can also distinguish between PD and multiple system atrophy.
Gal Bitan, PhD, from UCLA, answers our questions about his research on a potential blood test for diagnosing PD, which can also distinguish between PD and multiple system atrophy.
Gal Bitan, PhD, from UCLA,...
04/25/2019
Neurology

Advertisement

Advertisement